文献速递关节外科

肌肉松弛药在多模式镇痛方案中用于全膝关节置换术的疗效:一项前瞻性、双盲、安慰剂对照、随机试验

Efficacy of Muscle Relaxants on a Multimodal Analgesic Regimen in Total Knee Arthroplasty: A Prospective, Double-Blind, Placebo-Controlled, Randomized Trial.
PubMed 文献 · J Arthroplasty · 2025-08-12

这项前瞻性双盲安慰剂对照随机试验纳入120例初次全膝关节置换术患者,比较替扎尼定(2 mg每日三次,术后第1天起用14天)与安慰剂的镇痛效果。替扎尼定组在术后第3、7、14天行走时VAS疼痛评分显著降低,吗啡处方率降低,术后第3、7天膝关节活动度改善,但短暂嗜睡更常见。

要点

  • 替扎尼定组术后行走时VAS疼痛评分在术后第3、7、14天均显著低于安慰剂组。
  • 替扎尼定组吗啡处方率为24.1%,安慰剂组为42.9%(P=0.034)。
  • 替扎尼定组短暂嗜睡发生率为20.7%,安慰剂组为3.6%(P=0.015)。

核心结论

  • 在多模式镇痛方案中加入替扎尼定可提供有临床意义的术后行走时疼痛缓解,降低吗啡处方率,并促进膝关节活动度恢复。

研究设计与样本

  • 前瞻性、双盲、安慰剂对照随机试验,30天随访,纳入120例行初次全膝关节置换术患者,替扎尼定组58例、安慰剂组56例。

主要发现

  • 替扎尼定组较安慰剂组行走时VAS疼痛评分在术后第3天平均差值为-1.56(P<0.001),第7天为-2.40(P<0.001),第14天为-1.47(P<0.001)。
  • 替扎尼定组吗啡处方率为24.1%,安慰剂组为42.9%(P=0.034)。
  • 替扎尼定组较安慰剂组膝关节活动度在术后第3天平均差值为8.7°(P=0.012),第7天为6.7°(P=0.038)。
  • 替扎尼定组短暂嗜睡发生率为20.7%,安慰剂组为3.6%(P=0.015)。
  • 两组在炎症生物标志物、静息痛评分或Hospital for Special Surgery评分方面未观察到显著组间差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative muscle spasms markedly contribute to acute pain and restricted joint mobility after primary total knee arthroplasty (TKA). This study aimed to evaluate the efficacy of adding muscle relaxants as an adjunctive therapy in multimodal analgesic protocols for post-TKA pain management. METHODS: In this randomized trial with a 30-day follow-up, 120 patients undergoing TKA were assigned to receive either tizanidine (two mg three times daily for 14 days, starting on the first postoperative day) or placebo. The tizanidine group (n = 58) and placebo group (n = 56) had comparable baseline characteristics and surgical details (P > 0.05). Primary outcome was postoperative pain intensity, measured using the visual analog scale. Secondary outcomes included knee range of motion (ROM), Hospital for Special Surgery score, morphine consumption during hospitalization, serum levels of inflammatory biomarkers (C-reactive protein and interleukin-6), and complications. RESULTS: Tizanidine significantly reduced visual analog scale pain scores during ambulation on postoperative days three (mean difference: -1.56, P < 0.001), seven (mean difference: -2.40, P < 0.001), and 14 (mean difference: -1.47, P < 0.001), decreased the morphine prescription rate (24.1 versus 42.9%, P = 0.034), and improved knee ROM on day three (mean difference: 8.7°, P = 0.012) and day seven (mean difference: 6.7°, P = 0.038). Transient somnolence was significantly more frequent in the tizanidine group (20.7 versus 3.6%, P = 0.015). There were no significant intergroup differences observed in inflammatory biomarkers, resting pain scores, or Hospital for Special Surgery scores. CONCLUSIONS: Adding tizanidine to multimodal analgesia protocols provided clinically meaningful postoperative pain relief during ambulation, reduced the morphine prescription rate, and enhanced knee ROM recovery. These results may offer important implications for optimizing postoperative pain management strategies and inform future clinical practice guidelines for TKA recovery protocols.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Zhao L, Zhu X, Wang D, et al. Efficacy of Muscle Relaxants on a Multimodal Analgesic Regimen in Total Knee Arthroplasty: A Prospective, Double-Blind, Placebo-Controlled, Randomized Trial. J Arthroplasty. 2025. PMID: 40812459. doi:10.1016/j.arth.2025.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。